| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.17B | 16.50B | 16.11B | 15.48B | 14.42B | 14.30B |
| Gross Profit | 2.90B | 2.93B | 2.93B | 2.77B | 2.43B | 2.31B |
| EBITDA | 3.10B | 3.30B | 3.11B | 2.99B | 2.58B | 2.51B |
| Net Income | 1.34B | 1.35B | 1.37B | 1.58B | 1.08B | 1.03B |
Balance Sheet | ||||||
| Total Assets | 33.85B | 34.45B | 33.57B | 35.27B | 34.76B | 32.91B |
| Cash, Cash Equivalents and Short-Term Investments | 4.15B | 4.23B | 3.83B | 5.77B | 4.69B | 4.51B |
| Total Debt | 7.89B | 7.85B | 7.78B | 9.32B | 10.45B | 9.75B |
| Total Liabilities | 11.72B | 11.54B | 11.59B | 13.61B | 14.34B | 13.21B |
| Stockholders Equity | 22.12B | 22.92B | 21.98B | 21.66B | 20.42B | 19.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 832.69M | 564.69M | 1.96B | -172.43M | -9.14M |
| Operating Cash Flow | 0.00 | 2.61B | 2.03B | 2.57B | 2.14B | 1.80B |
| Investing Cash Flow | 0.00 | -1.82B | -1.34B | 8.31M | -2.31B | -1.79B |
| Financing Cash Flow | 0.00 | -447.81M | -2.60B | -1.50B | 344.51M | 959.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥85.26B | 11.81 | ― | 3.48% | 1.42% | 32.92% | |
74 Outperform | ¥15.93B | 10.60 | ― | 3.37% | 2.44% | 3.81% | |
70 Outperform | ¥146.10B | 10.77 | ― | 3.65% | 3.06% | 1.48% | |
70 Outperform | ¥14.36B | 9.45 | ― | 3.85% | 8.49% | 32.73% | |
69 Neutral | ¥18.97B | 7.10 | ― | 2.46% | -0.28% | 15.95% | |
65 Neutral | ¥13.57B | 9.42 | ― | 3.04% | 3.34% | 11.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |